PREVENTIV MEASURES
DEAD

Serial Number

77860437

Owner

SAGENT HOLDING CO.

Attorney

Marcia Ireland Rosenfeld

Filing Date

Oct 29, 2009

Add to watchlist:

No watchlists yet
View on USPTO

PREVENTIV MEASURES Trademark

Serial Number: 77860437

PREVENTIV MEASURES is a trademark filed by SAGENT HOLDING CO. on October 29, 2009. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

SAGENT HOLDING CO. (19 trademarks)

UGLAND HOUSE, SOUTH CHURCH STREET
GEORGETOWN , KY

Entity Type: 03

Trademark Details

Filing Date

October 29, 2009

Registration Date

Not Registered

Goods & Services

Labels sold as an integral component of pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, anti-infectives, anti-inflammatory agents, anticonvulsants, antiemetics, anxiolytics, blood modifiers, cardiovasculars, diuretics, hormones, diluents, oncolytics, transplantation agents, imaging agents, vascular targeting agents, cancer treatments, and vascular disease treatments; Labels sold as an integral component of pre-filled syringes sold filled with alkalizing agents, labels sold as an integral component of pre-filled syringes sold filled with analgesics and anesthetics, labels sold as an integral component of pre-filled syringes sold filled with antacids, labels sold as an integral component of pre-filled syringes sold filled with anticholinergics, labels sold as an integral component of pre-filled syringes sold filled with anti-infectives, labels sold as an integral component of pre-filled syringes sold filled with anti-inflammatory agents, labels sold as an integral component of pre-filled syringes sold filled with anticonvulsants, labels sold as an integral component of pre-filled syringes sold filled with antiemetics, labels sold as an integral component of pre-filled syringes sold filled with anxiolytics, labels sold as an integral component of pre-filled syringes sold filled with blood modifiers, labels sold as an integral component of pre-filled syringes sold filled with cardiovasculars, labels sold as an integral component of pre-filled syringes sold filled with diuretics, labels sold as an integral component of pre-filled syringes sold filled with hormones, labels sold as an integral component of pre-filled syringes sold filled with diluents, labels sold as an integral component of pre-filled syringes sold filled with oncolytics, labels sold as an integral component of pre-filled syringes sold filled with transplantation agents, labels sold as an integral component of pre-filled syringes sold filled with imaging agents, labels sold as an integral component of pre-filled syringes sold filled with vascular targeting agents, labels sold as an integral component of pre-filled syringes sold filled with cancer treatments, and labels sold as an integral component of pre-filled syringes sold filled with vascular disease treatments; Labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of pain; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of infections; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of cardiovascular disease; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of hormonal imbalances; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of heartburn; labels sold as an integral component of injectable drugs and therapeutic solutions for imaging; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of pain sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of infections sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of cardiovascular disease sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of hormonal imbalances sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of heartburn sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for imaging sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Sep 29, 2010 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 29, 2010 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 4, 2010 GNRN
NON-FINAL ACTION E-MAILED
Feb 4, 2010 GNRT
NON-FINAL ACTION WRITTEN
Feb 4, 2010 CNRT
ASSIGNED TO EXAMINER
Feb 3, 2010 DOCK
NOTICE OF PSEUDO MARK MAILED
Nov 5, 2009 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2009 NWOS
NEW APPLICATION ENTERED
Nov 2, 2009 NWAP